High-Quality Melanotan II (MT2) 10mg Suppliers, Companies

Size: 10mg Contents: Melanotan  II (10mg) Form: Lyophilized powder Purity: >99%

Product Description

I. Basic Information
Name Melanotan II (MT-II)
Purpose & Background To darken skin color by stimulating melanin production.
Regulatory Status Not FDA approved; discussed only in research/over-the-counter settings.
Common Method of Use Subcutaneous injection (SubQ)
II. Usage Phase Division (Logical Framework)
Loading Phase Standard
Purpose: To allow the body to gradually adapt and reduce the risk of adverse reactions.
Characteristics:
  • Start with a low dose
  • Gradually increase the dose every 1–2 weeks
  • Usually once daily
Common Approach (Not a Recommendation):
  • Initial Phase: Low dose (e.g., 250 mcg)
  • Middle Phase: Medium dose (e.g., 500 mcg)
  • Late Phase: Higher dose (e.g., 1 mg)
Intensive Phase Optional
Purpose: To promote faster pigmentation.
Characteristics:
  • Faster dose escalation
  • Higher incidence of side effects
  • More suitable for experienced users
Maintenance Phase Ongoing
Purpose: To maintain the achieved skin tone.
Characteristics:
  • No longer used daily
  • Switch to 1–2 times per week
  • Dosage is usually lower than or equal to that of the Intensive Phase
III. Common Dosage Ranges
Phase Typical Dose Range (commonly cited) Frequency
Loading 250–500 mcg Daily
Advanced 500–1000 mcg Daily
Maintenance 500–1000 mcg 1–2× per week
Individual tolerance varies significantly. Higher doses are not inherently safer or more effective.
Frequently Asked Questions (FAQ)
What is Melanotan II (MT-II)?
Melanotan II (MT-II) is a compound used to darken skin color by stimulating melanin production in the body.
Is Melanotan II approved by the FDA?
No, Melanotan II is not FDA approved. Its use is discussed only in research or over-the-counter settings.
What is the common method of administration for MT-II?
The most common method of use for Melanotan II is via subcutaneous injection (SubQ).
What is the primary purpose of the Loading Phase?
The purpose of the Loading Phase is to allow the body to gradually adapt to MT-II and to reduce the risk of potential adverse reactions.
How often is MT-II typically administered during the Maintenance Phase?
During the Maintenance Phase, MT-II is no longer used daily; instead, usage switches to approximately 1–2 times per week to preserve the achieved skin tone.
Does taking a higher dosage guarantee better or safer results?
No. Individual tolerance varies significantly, and higher doses are not inherently safer or more effective.

Related Products